 |
0 Diseases |  |
0 Trials |
|
0 Trials |  |
10 News |  |
- | Life 5000 (human chorionic gonadotrophin) / Abbott
Journal: Consensus Statements for Assessment and Management of Threatened Miscarriage in the First Trimester in Pakistan: A Three-Step Modified Delphi Approach. (Pubmed Central) - Aug 22, 2024
These consensus statements aggregated the best available evidence and experts' opinion-supported statements to improve patient education, risk assessment, diagnosis, and evaluation as well as management of threatened miscarriage during the first trimester in Pakistan.
- | Journal: Lack of observed interference by therapeutic monoclonal antibodies in select commonly utilized immunoassays. (Pubmed Central) - Dec 4, 2023
These findings demonstrate no detectable tmab interference for the assessed immunoassays using spiked preparations of the tmabs in residual human sera. The findings are limited to the tmabs and immunoassays studied here.
- | Life 5000 (human chorionic gonadotrophin) / Abbott
Journal: Ambulatory human chorionic gonadotrophin (hCG) testing: a verification of two hCG point of care devices. (Pubmed Central) - Oct 27, 2023
Both hCG POCT devices were verified for use in clinical practice. Practical factors must also be considered when choosing which device to use in each unit.
- | Life 5000 (human chorionic gonadotrophin) / Abbott
Journal: Utility of Commercially Available Quantitative hCG Immunoassays as Tumor Markers in Trophoblastic and Non-Trophoblastic Disease. (Pubmed Central) - May 19, 2023
Further harmonization of hCG methods is needed as serial testing for biochemical tumor monitoring must still be performed using a single method. Additional studies are needed to assess the utility of quantitative hCG as a tumor marker in other malignant disease.
- | Life 5000 (human chorionic gonadotrophin) / Abbott
Journal: A high-rate and long-life aqueous rechargeable Mg-ion battery based on an organic anode integrating diimide and triazine. (Pubmed Central) - Jan 18, 2023
Results showed remarkable outcomes of 3D-P(PDI-T) anode: an extremely high rate capacity-358 mAh g-1 at 0.05 A g-1; 3D-P(PDI-T)‖Mg2MnO4 full cell: significant reversible capacity-148 mAh g-1 and long cycle life-5000 cycles at 0.5 A g-1...The assembled 3D-P(PDI-T)‖Mg2MnO4 full cell exhibited a capacity retention of around 95% after 5000 cycles at 0.5 A g-1. This anode-3D-P(PDI-T) electrode sustained its special framework structure during the discharge/charge cycles of Mg-ion batteries. Our results provide strong support for a cutting-edge molecular engineering technique for improved organic materials that facilitate the efficient charge-storage behavior of aqueous Mg-ion batteries.
- | Life 5000 (human chorionic gonadotrophin) / Abbott
Journal: Pregnancy disrupts the accuracy of automated fT4 immunoassays. (Pubmed Central) - Oct 12, 2022
Our results indicate that immunoassays overestimate fT4 in pregnant women, which might lead to an overestimation of thyroid status. Physicians and laboratory specialists should be aware of this phenomenon to avoid drawing false conclusions about thyroid function in pregnant women.